Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice-Reference-Cited by-同舟云学术

Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice

Published:2020-01 Issue:1 Volume:10 Page:1-11
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Michaličková Danica¹,Jansa Pavel²,Bursová Miroslava³,Hložek Tomáš³⁴,Čabala Radomír³⁴,Hartinger Jan Miroslav¹,Ambrož David²,Aschermann Michael²,Lindner Jaroslav⁵,Linhart Aleš²,Slanař Ondřej¹,Krekels Elke H.J.⁶

Affiliation:

1. Institute of PharmacologyFirst Faculty of Medicine & General University HospitalCharles UniversityPragueCzech Republic

2. 2nd Department of Medicine – Department of Cardiovascular MedicineFirst Faculty of MedicineCharles University and General University HospitalPragueCzech Republic

3. Institute of Forensic Medicine and ToxicologyFirst Faculty of MedicineCharles University and General University HospitalPragueCzech Republic

4. Department of Analytical ChemistryFaculty of ScienceCharles UniversityPragueCzech Republic

5. 2nd Department of Surgery – Department of Cardiovascular SurgeryFirst Faculty of MedicineCharles University and General University HospitalPragueCzech Republic

6. Division of Systems Biomedicine and PharmacologyLeiden Academic Centre for Drug ResearchLeiden UniversityLeidenThe Netherlands

Funder

Univerzita Karlova v Praze

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894019898031

Reference19 articles.

1. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT);Galiè N;Eur Heart J,2016

2. Definitions and diagnosis of pulmonary hypertension;Hoeper MM;J Am Coll Cardiol,2013

3. Chronic thromboembolic pulmonary hypertension (CTEPH) results from an international prospective registry;Pepke‐Zaba J;Circulation,2011

4. Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study;McLaughlin VV;BMC Pulm Med,2017

5. Riociguat for the treatment of pulmonary hypertension;Schermuly RT;Expert Opin Inv Drug,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sensitive CE‐MS method for monitoring of riociguat and desmethylriociguat levels in human serum;ELECTROPHORESIS;2020-07-31